AI Transforming Healthcare

Generative AI won’t replace the relationship between doctors and patients. But it will help doctors do their jobs. Push pharmaceutical companies, medical technology firms, and other health care organizations improve what they do and how they do it.

Health care is deeply personal. It is also one of the areas where artificial intelligence could change the most. Generative AI, in particular, could help doctors improve results for patients, shorten the time it takes to develop new medicines, and support many other advances.

But health care is also where people feel the most cautious about AI. Many are uncomfortable with the idea that software could influence major medical choices. There are other serious concerns as well. AI systems can reflect bias, produce wrong or misleading answers, and create new risks for patient privacy.

Those worries are reasonable. Even so, the potential upside is too large to ignore. If AI is designed and used carefully, it can help clinicians catch problems earlier and make diagnoses more precise. It can support treatments that fit each person’s needs and streamline how care is delivered. It may also improve overall wellness and reduce costs for both patients and health care organizations. And by reaching communities that have been left out or under-served, AI could play a meaningful role in closing health equity gaps.

A Major Boost for Research and Development

AI is already changing how pharmaceutical companies do research and development. During the COVID-19 pandemic, vaccines were created at record speed. That progress was supported by tools like robotic automation, AI-driven methods, and machine-learning systems, which helped teams run more tests, process more data, and move faster.

Now generative AI is pushing things forward even more. It can help identify new drug ideas, improve how clinical trials are designed and run, and support treatments that are tailored to specific patients. Over time, that can make care more effective and, in many cases, more affordable and easier to access.

Some companies report that with generative AI, they can move from finding a promising drug target to receiving FDA approval in about 18 months. They also claim they can do it at a much lower cost than the traditional development process.

10X the process for generating new protein an drug molecules _BCG

60% reduced time spent on administration _BCG

Using generative AI during clinical development could help medicines reach the market even faster. As the cost of developing drugs goes down, it may become more realistic to invest in treatments for rare diseases that were once too expensive to pursue.

Generative AI may also improve how researchers use patient information. It can sift through large data sets to spot smaller groups of patients who are more likely to benefit from a specific treatment. It might even help predict how a disease could change over time and become resistant to certain drugs, which would support more personalized treatment plans.

Generative AI could also reshape how drug makers work with regulators. If development speeds up, more drugs will enter the approval pipeline at once. To keep pace, regulators will likely need to adopt their own generative AI tools to review data and manage the increased workload.

Computers are becoming excellent at looking at medical pictures. Some AI tools are already better than human experts at spotting signs of cancer in X-rays. In the future, AI might watch over patients all day long to catch problems before they get worse.

One of the most amazing ideas is that smartphones might soon be able to "smell" sickness. This could help find diseases like multiple sclerosis just by using the sensors in your phone. If we find a sickness early, it is much easier to treat.

A Major Shift in Diagnosis and Patient Care

AI is becoming a powerful tool for diagnosing disease. In some areas, visual AI systems can already match or even beat radiologists at spotting certain cancers. Many startups, along with major technology companies, are also building generative AI tools for oncology, with the goal of finding cancer earlier and improving detection.

Looking ahead, generative AI could help monitor patients in real time. By combining continuous tracking with data analysis, it could produce personalized insights and flag warning signs sooner. That could lead to faster treatment before a condition gets worse.

Generative AI could also support prevention and day-to-day wellness. It may encourage healthier choices through tailored reminders and guidance delivered through mobile apps, wearables, and other monitoring devices. Over time, this could lower the need for hospital visits by helping people manage issues earlier.

AI Improving Wellness

AI helps people better monitor and manage their own health and wellness. Some examples:

• Even today, AI-driven wearables help people monitor basic health and fitness information, like step counts and heart rate.
• AI apps can also support mental health. Some check in with users through short daily conversations, track changes in mood, spot possible signs of stress or depression, and recommend simple next steps.
• Other tools act like digital health coaches. They can help people stay on top of chronic conditions such as high blood pressure and diabetes by offering reminders, guidance, and progress tracking.
• In the next few years, smartphones may also be able to detect odors. If that happens, they could potentially flag diseases like cancer or multiple sclerosis that may produce specific smells. That could lead to earlier detection and, in some cases, more effective treatment.

In primary care, AI could take over some routine parts of a doctor visit or make them more effective. For example, it can review a patient’s electronic health record, flag potential concerns, and send reminders or recommendations based on medical evidence.

Pharmacies may also use “emotional AI” tools that can analyze conversations, pick up on signs of frustration or worry, and suggest ways to respond with more empathy. In addition, chatbots powered by generative AI could offer mental health support that is easier to access and less expensive than many traditional options.

Still, health care is personal, and emotions matter. Most patients will want a real doctor to share serious news and explain what it means. AI can assist, but it cannot replace human care and connection.

Changing How Health Care Works

Generative AI is starting to reshape the business side of health care. Many new uses are being tested across the industry.

Pharmaceutical are using GenAI to explore new treatments, including small “mini-proteins” that could help treat rare cancers, especially in groups that have often been underserved. They are also combining deep-learning tools with synthetic biology to design new antibody treatments for cancer and immune-related diseases. In addition, some teams are building language-model systems that can propose new protein sequences with specific features. That approach could become a new way to design medicines and expand access to lower-cost treatments.

At the same time, services like Nvidia’s generative AI cloud offerings are giving biopharma teams access to large foundation models trained on data from genomics, chemistry, biology, and molecular dynamics. These services may include ready-to-use GenAI models, and they can also let researchers customize the tools using their own private data.

Medtech could use GenAI to build devices that better match each patient, such as prosthetics and implants designed around individual needs. These devices may also include software that can spot early problems and suggest maintenance before something breaks. GenAI platforms are also being explored for brain health. For example, they could help track signs of brain aging and support earlier detection of cognitive decline linked to mental health conditions or neurodegenerative disorders.

Looking ahead, remote monitoring may become more capable as these systems collect and analyze more patient data outside the clinic. That could lead to faster, better-timed interventions. GenAI could also strengthen quality control by predicting when equipment is likely to fail, so repairs can be scheduled in advance and downtime is reduced.

85% CAGR projected GenAI growth though 2027 _BCG

$22b total market size by 2027 _BCG

Payers and providers are beginning to use GenAI to improve risk management, lower costs, and engage members more effectively. Early examples include automating parts of underwriting and claims, and using predictive models to spot high-risk groups based on medical history, demographics, and social factors that affect health. The goal is to intervene sooner, prevent avoidable complications, and make care more fair.

For health systems and clinics, GenAI can also reduce administrative workload. It may automate documentation, support claims processing, draft preauthorization or appeal letters, and streamline patient onboarding and scheduling. When routine tasks take less time, clinicians and staff can spend more time with patients.

Public health organizations may use GenAI to plan resources and respond faster to emerging threats. For instance, AI-based early warning systems could help detect new COVID-19 variants sooner and alert researchers, vaccine developers, health leaders, and policymakers. These tools could also support reviews of drug safety and effectiveness. Over time, public health teams may use AI to forecast outbreaks and move supplies and staff quickly to reduce harm.

A Careful, Responsible Approach to AI in Health Care

To deliver on AI’s potential, hospitals and other health organizations need to use generative AI in a safe and responsible way. That means taking the risks seriously and putting strong safeguards in place, including:

• Bias. Generative AI can repeat unfair patterns that exist in the data it learns from. Organizations should have qualified experts review training data and AI results, then fix gaps or imbalances that could lead to unequal care.
• Misinformation. AI models are improving, but they can still produce answers that sound confident while being wrong. To earn trust, health systems should require human review before AI outputs are used in real clinical decisions.
• Privacy. Patient information must be protected at the highest level. Organizations should be clear about who owns the data when working with partners, improve cybersecurity, and consider using synthetic data when appropriate.
• Lack of transparency. Many AI tools can feel like a “black box,” which makes people uneasy. Providers should explain how the system is used, what data it relies on, and how it contributes to a recommendation or risk estimate.
• Misuse. AI outputs can look convincing, but they are not the final word. Hospitals, clinicians, and insurers should make it clear that AI is a support tool. It can offer suggestions, but it does not replace professional judgment or a full medical evaluation.

Generative AI is likely to drive major progress in medicine. Still, the heart of health care will remain the same: people caring for people. When used with care and oversight, AI can strengthen that relationship rather than replace it.

‍

‍